Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BWC0977 in Healthy Volunteers
NCT05942820Phase 1Terminated
- Sponsor
- Bugworks Research Inc.
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bacterial infection comparing BWC0977 with Placebo (2 arms). Primary endpoint: Incidence of treatment-emergent adverse events up to 15 days. Started Aug 2023; status: terminated.
02
Drugs
BWC0977
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05942820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05942820.